Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Tumor-infiltrating clonal hematopoiesis is associated with adverse clinical outcomes in diffuse large B-cell lymphoma.

Blood cancer discovery·2026
Same author

Tumour-Derived Extracellular Vesicles Induce Diffuse Large B-Cell Lymphoma Progression Through Macrophage-Mediated MDSC Accumulation.

Journal of extracellular vesicles·2026
Same author

N6-methyladenosine reader IGF2BP2 in T-cell lymphoma.

Blood·2026
Same author

Highly flexoelectric response for uranium removal and recovery using the organic-inorganic hybrid material.

Nature communications·2026
Same author

Efficacy and safety of low-concentration whitestrips for extrinsic tooth discoloration: a randomized controlled trial.

Frontiers in oral health·2026
Same author

Responsibly Translating ARFID Screens in DGBI.

Gastroenterology·2026
Same journal

Transplantation tolerance versus immune evasion: Mechanistic divergences and therapeutic frontiers for islet cell replacement.

Cell reports. Medicine·2026
Same journal

Differential T cell clonal dynamics underlie outcomes to frontline chemoimmunotherapy in advanced gastric cancer.

Cell reports. Medicine·2026
Same journal

Targeted DNA triplex-forming oligonucleotide liposome for pulmonary fibrosis gene therapy.

Cell reports. Medicine·2026
Same journal

Metabolomic and lifestyle profiles refine BMI-metabolic phenotypes in older adults.

Cell reports. Medicine·2026
Same journal

Targeting cytokine-like protein FAM3D alleviates atherosclerosis.

Cell reports. Medicine·2026
Same journal

High-dose furmonertinib as first-line treatment for untreated EGFR-mutated advanced NSCLC with central nervous system metastases: A phase 2 trial.

Cell reports. Medicine·2026
查看所有相关文章

相关实验视频

Updated: May 21, 2025

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

9.7K

使用数字病理学在扩散大B细胞淋巴瘤中的实用微环境分类.

Yu-Qing Wang1, Shuo Wang2, Hong-Mei Yi3

  • 1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.

Cell reports. Medicine
|March 20, 2025
PubMed
概括
此摘要是机器生成的。

一种新方法使用免疫组织化学分类扩散性大B细胞淋巴瘤 (DLBCL) 亚型,改进了转录组分类. 这种方法揭示了DLBCL患者的生存差异和潜在的治疗目标.

关键词:
算法算法是一种算法.原始细胞的起源细胞扩散大的B细胞淋巴瘤.数字病理学数字病理学免疫逃避 免疫逃避免疫疗法 免疫疗法淋巴瘤微环境是一个微环境.

更多相关视频

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

2.2K
Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
07:52

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma

Published on: January 9, 2019

19.7K

相关实验视频

Last Updated: May 21, 2025

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

9.7K
Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

2.2K
Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
07:52

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma

Published on: January 9, 2019

19.7K

科学领域:

  • 血液学 血液学 血液学
  • 在瘤学瘤学.
  • 免疫学 免疫学 免疫学
  • 病理学 病理学 病理学

背景情况:

  • 扩散性大B细胞淋巴瘤 (DLBCL) 是一种异质癌症,其结果受到瘤及其微环境的影响.
  • 基于淋巴瘤微环境 (LME) 的DLBCL亚型的现有转录组分类很难在临床上实施.

研究的目的:

  • 通过免疫组织化学和数字病理学开发和验证DLBCL的实用LME分类.
  • 为了将这种新的分类与患者的生存率和免疫逃生机制相关联.

主要方法:

  • 使用解卷法来量化来自免疫组织化学染色的微环境成分 (CD3,CD8,CD68,PD-L1,原).
  • 开发了一种基于染色的LME分类算法,与基于转录组的亚型和单细胞测序数据进行验证.
  • 分析了DLBCL患者在LME亚型中接受R-CHOP或R-CHOP-X免疫化疗的生存结果 (整体和无进展).

主要成果:

  • 基于免疫组织化学的LME分类显示,与转录组亚型的一致性超过80%.
  • 由算法识别的独特的免疫微环境与转录基因概况保持一致.
  • 在标准和高级免疫化学疗法后,在LME亚型中观察到显著的生存差异.

结论:

  • 开发的基于免疫组织化学的算法为基于LME的DLBCL亚型的分类提供了一种可行的方法.
  • LME亚型与差异性免疫逃生机制有关,这表明特定的免疫治疗点.
  • 这种分类在DLBCL的精密医学试验中具有潜在的应用.